Ischemia Reperfusion Injury clinical trials

Explore recruiting ischemia reperfusion injury clinical trials.

Recruiting ischemia reperfusion injury studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ischemia Reperfusion Injury trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Alkaline Phosphatase as treatment of Ischemia Reperfusion Injury to prevent delayed graft function

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Ischemia Reperfusion Injury trials by city

Ischemia Reperfusion Injury clinical trials

Recruiting ischemia reperfusion injury studies right now

Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury

A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Remote Ischaemic Conditioning in STEMI Patients in AFRICA

Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors

Kidney Protective Jacket

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation

Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation

The Danish Out-of-Hospital Cardiac Arrest Study

Also recruiting in Europe

Alkaline Phosphatase as treatment of Ischemia Reperfusion Injury to prevent delayed graft function

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Ischemia Reperfusion Injury trials by city

Other conditions